Skip to content Skip to footer
Spotlight Interview_Philippe Barillon

Reuters Pharma 2025: Pre-Conference Talks Featuring Philippe Barillon

Philippe Barillon joins PharmaShots Managing Editor Himanshu Sehgal for an enlightening dialogue exchange in a Pre-Conference Talk.Philippe will be joining the upcoming Reuters Events Pharma 2025 as a panelist for the topic “Bridging gaps: Leverage data, tech and RWE for enhanced healthcare access and market growth”.Philippe highlights the potential applications of RWEs using…

Read more

Spotlight Interview_Konrad Dobschuetz

Reuters Pharma 2025: Pre-Conference Talks Featuring Konrad Dobschuetz

Konrad Dobschuetz, Founder Director at Leap Advisory & Intelligence will be conducting a workshop at the upcoming Reuters Events Pharma 2025 on the topic “Patient Centricity”. In the exclusive discussion with PharmaShots, Konrad addresses the need for biopharma companies to achieve a patient mindset to deliver patient-centric care and enhance the patient experience.Konrad believes…

Read more

Spotlight Interview_Rahul Mittal

Reuters Pharma USA 2025: Post-Conference Talks featuring Rahul Mittal

Brimming with insightful panel discussions, presentations on disruptive technologies, and illuminating real-world evidence shaping the healthcare landscape now and then, the two-day Reuters event celebrated pharmaceutical innovation and fresh perspectives pouring into the interactive sessions.In the panel discussion at Reuters Pharma USA 2025, Rahul Mittal outlined ways to enhance patient centricity and engagement. Rahul…

Read more

Spotlight Interview_Heba Nowyhed

CXO Talks: Heba Nowyhed from Arcellx in a Candid Conversation with PharmaShots

CAR T-cell therapies hold a promising foothold in addressing unmet healthcare needs. Arcellx, a clinical-stage biotech company, is steadfastly exploring the potential of cell therapy in RRMM and generalized myasthenia gravis patients with its lead asset anito-cel. During presentations at ASH, anito-cel demonstrated no delayed neurotoxicity in both P-1 and pivotal P-II clinical trials for multiple myeloma.…

Read more

Spotlight Interview_T.J.Sharpe

Reuters Pharma USA 2025: Pre Conference Talks featuring T.J. Sharpe

With breakthrough discoveries addressing patients' unmet needs, caregivers, decision-makers, and advocacy groups have made great strides towards bringing patient experience to the mainstream. Today's guest is TJ Sharpe, a Patient Insights Expert and Stage-IV Melanoma survivor. In his topic "Complicating is easy, Simplifying is Difficult, the personalized patient experience", T.J. will shed light on patient…

Read more

Key Takeaways of J.P. Morgan Healthcare Conference 2025

Key Takeaways of J.P. Morgan Healthcare Conference 2025

Shots: The 43rd Annual J.P. Morgan Conference took place from 13th to 16th January in San Francisco, USA. J.P. Morgan Healthcare Conference serves as a pioneering hub that features presentations and dialogues on the advances of the healthcare industry by bringing healthcare professionals, researchers, manufacturers, and other healthcare stakeholders to one platform.  Innovation remained the…

Read more

Spotlight Interview_UWE Tigor_JED Litwinuik

CXO Talks: Jed Litwiniuk & Uwe Tigör from Auxilius Pharma in a Riveting Dialogue Exchange with PharmaShots

In this fifth episode of our recently launched CXO Talks, we spoke with a distinguished panel of speakers from Auxilius Pharma, Jed Litwiniuk, the CEO, and Uwe Tigör, the CMO of the company. Auxilius Pharma is an emerging specialized pharma company aimed at developing, optimizing, and delivering well-established medications internationally.  Jed & Uwe walked memory…

Read more

Spotlight Interview_Rashmi Gurnani

CXO Talks: Rashmi Gurnani from AKT Health Analytics in a Riveting Dialogue Exchange with PharmaShots

In the fourth reprise of our recently launched Complimentary Exclusive Video Interview, we have Rashmi Gurnani CEO of AKT Health Analytics. Rashmi sheds light on AKT’s distributor partnership with Certara, known for delivering global drug development solutions to pharmaceutical companies and CROs. While discussing AKT’s role in assisting the US clients with Japan’s PMDA’s approval,…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]